FBRX - NASDAQ

Forte Biosciences, Inc.

Forte Biosciences, Inc.

FBRX·NASDAQ

$16.74

-7.9%
HealthcareBiotechnology

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$232.47M
EPS-4.7100
P/E Ratio-3.55
Earnings Date08/13/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Forte Biosciences, Inc.

Forte Biosciences, Inc. Earnings Call Transcripts

FBRX · NASDAQ

2021

1
Q1
May 11
Q2
N/A
Q3
N/A
Q4
N/A

Related Guides

Blog Categories

Continue your FBRX research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.